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The difference in intraoperative analge-
sic consumption was likely small. There
was no statistically significant difference
in sex (P = 0.459), age (P = 0.700), or
duration of anesthesia (P = 0.363) be-
tween the study groups. Moreover, inclu-
sion criteria for the present study were that
patients were generally healthy and under-
went surgical treatment of ‘simple’ man-
dibular, zygomatic, or orbital fractures
that were managed with standardized sur-
gical methods. No severe, comminuted, or
multiple facial fractures requiring exten-
sive surgery were included. In addition,
approaches were exclusively local, i.e.,
extraoral approaches in mandibular frac-
tures, and no coronal approaches were
used in zygomatic fractures.Intraoperative pain control was stan-
dardized as follows: Each patient received
0.1–0.2 mg fentanyl during induction of
anesthesia. During surgery, a bolus of
fentanyl (0.05–0.1 mg) was given if the
patient’s heart rate and/or systolic blood
pressure increased by 15%.
Ondansetron was not given routinely to
all patients. It was used as a rescue and
administered immediately when patients
needed it.
Of the 119 patients included in the
study, 96 received opioids after surgery:
45 were in the study group and 51 were in
the control group; this difference was not
statistically significant (P = 0.2269).
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